These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 16736564)
1. New tuberculosis therapy offers potential shorter treatment. Phase III trials planned in Africa. Saudi Med J; 2006 Apr; 27(4):573-4. PubMed ID: 16736564 [No Abstract] [Full Text] [Related]
2. Prospects for new tuberculosis treatment in Africa. Mwinga A; Bernard Fourie P Trop Med Int Health; 2004 Jul; 9(7):827-32. PubMed ID: 15228494 [TBL] [Abstract][Full Text] [Related]
8. The role of surgery and fluoroquinolones in the treatment of multidrug-resistant tuberculosis. Törün T; Tahaoğlu K; Ozmen I; Sevim T; Ataç G; Kir A; Güngör G; Bölükbaşi Y; Maden E Int J Tuberc Lung Dis; 2007 Sep; 11(9):979-85. PubMed ID: 17705975 [TBL] [Abstract][Full Text] [Related]
9. Treatment of multidrug-resistant tuberculosis: should you try this at home? Griffith DE Am J Respir Crit Care Med; 2004 May; 169(10):1082-3. PubMed ID: 15132956 [No Abstract] [Full Text] [Related]
10. Use of fluoroquinolone antibiotics leads to tuberculosis treatment delay in a South African gold mining community. Jeon CY; Calver AD; Victor TC; Warren RM; Shin SS; Murray MB Int J Tuberc Lung Dis; 2011 Jan; 15(1):77-83. PubMed ID: 21276301 [TBL] [Abstract][Full Text] [Related]
11. Does the use of fluoroquinolones for the empiric treatment of pneumonia delay initiation of treatment of tuberculosis? Abiad H Clin Infect Dis; 2002 Dec; 35(12):1572; author reply 1572-3. PubMed ID: 12471582 [No Abstract] [Full Text] [Related]
15. Early clinical development of anti-tuberculosis drugs: science, statistics and sterilizing activity. Davies GR Tuberculosis (Edinb); 2010 May; 90(3):171-6. PubMed ID: 20382567 [TBL] [Abstract][Full Text] [Related]
16. Fluoroquinolones: a new treatment for tuberculosis? Gillespie SH; Kennedy N Int J Tuberc Lung Dis; 1998 Apr; 2(4):265-71. PubMed ID: 9559396 [TBL] [Abstract][Full Text] [Related]
17. New paradigm in dose-finding trials: patient-specific dosing and beyond phase I. Rogatko A; Babb JS; Tighiouart M; Khuri FR; Hudes G Clin Cancer Res; 2005 Aug; 11(15):5342-6. PubMed ID: 16061846 [TBL] [Abstract][Full Text] [Related]